Fundradar!Italy Beta
Get Signals
← Back to all funds

Anima Alternative SGR

Submit feedback

Website

Address

Milan

Contact

Philippe Minard, Andrea Cappuccio
Private DebtIndustrialHealthcareBusiness ServicesFood & AgricultureReal Estate & ConstructionConsumer & RetailTechnologyTransport & Logistics

Acts as the alternative investment arm of Anima Holding, a major Italian independent asset management group, providing hybrid capital solutions to support the growth and succession of domestic SMEs like Eurovetrocap.

€353M

AUM

2

Funds

9

Executives

1

Green Funds

Investment Profile

Investment Range

€2M - €20M

Focus

Buy Out, Expansion, Replacement

Geographies

Italy

Assets (35 of 39)

11
Industrial Manufacturing
5
Healthcare
4
Professional Services
2
Construction
2
Food & Beverage
2
Packaging
1
Certification & Engineering
8
Other
AssetStatus ↑SectorHQSourceEntry Date
▶Alliance Medical Italia S.r.l
CurrentHealthcareLissoneWebsite-
▶Bat S.p.A
CurrentIndustrial ManufacturingNoventa di PiaveWebsite-
CurrentHealthcareLissoneWebsite-
CurrentTransportation & LogisticsFara Gera d'AddaWebsite-
▶BV Tech
CurrentTechnologyMilanWebsite-
▶Ceme S.p.A
CurrentIndustrial ManufacturingTrivolzioWebsite-
▶Cofimco S.r.l
CurrentIndustrial CoolingPombia (NO)Website-
▶Conformgest S.p.A
CurrentFinancial ServicesBiellaWebsite-
▶Datlas
CurrentProfessional ServicesMilanWebsite-
▶Dea / ELMO Group
CurrentIndustrial ManufacturingPiovene RocchetteWebsite-
▶Eurovetrocap S.p.A
CurrentPackagingTrezzano sul NaviglioWebsite-
▶Fassi Gru S.p.A
CurrentIndustrial ManufacturingAlbinoWebsite-

Showing 1–12 of 35 assets

Page 1 of 3

People Analyticsn=25

Signals (2)

Portfolio
2025-06-27

Neopharmed Gentili signed an agreement to acquire BioCryst's ORLADEYO business in Europe for up to $264M, including $250M upfront and milestone payments

Source: BioCryst
Debt
2024-10-01

Ceme completed a financing package including €360M senior secured notes and a €67.5M revolving credit facility

Source: White & Case

Showing 1–2 of 2 signals